Next Article in Journal
Effects of Crude Fucus distichus Subspecies evanescens Fucoidan Extract on Retinal Pigment Epithelium Cells―Implications for Use in Age-Related Macular Degeneration
Previous Article in Journal
Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 17
Issue 9
10.3390/md17090537
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Update on Monoterpenes from Red Macroalgae: Isolation, Analysis, and Bioactivity

by
Ana-Marija Cikoš
1,
Mladenka Jurin
2,
Rozelindra Čož-Rakovac
2,
Stela Jokić
1 and
Igor Jerković
3,*
1
Faculty of Food Technology Osijek, University of Josip Juraj Strossmayer in Osijek, 31000 Osijek, Croatia
2
Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia
3
Faculty of Chemistry and Technology, University of Split, R. Boškovića 35, 21000 Split, Croatia
*
Author to whom correspondence should be addressed.
Mar. Drugs 2019, 17(9), 537; https://doi.org/10.3390/md17090537
Submission received: 22 August 2019 / Revised: 10 September 2019 / Accepted: 13 September 2019 / Published: 16 September 2019
Browse Figures
Versions Notes

Abstract

:
Macroalgae produce a wide range of monoterpenes as secondary metabolites of mevalonate (MVA) and/or methylerythritol phosphate (MEP) pathway (often including haloperoxidase action). Great biodiversity of macroalgal monoterpenes was reported including acyclic, monocyclic, and bicyclic structures. Halogenated monoterpenes exhibited significant biological activity (e.g., anticancer, antiplasmodial, and insecticidal) that is influenced by the number of present halogens (higher halogen content is preferable, especially bromine) and their position within the monoterpene skeleton. In distinction from the existing reviews, the present review provides novelty with respect to: (a) exclusively monoterpenes from red macroalgae are targeted; (b) biosynthesis, isolation, and analysis, as well as bioactivity of monoterpenes are represented; (c) the methods of their isolation, analysis, and structure elucidation are summarized; (d) the bioactivity of macroalgal monoterpenes is systematically presented with emphasis on anticancer activity; (e) the literature references were updated.

1. Introduction

Natural organic compounds exhibited a significant role in the development of new drugs [1] and often serve as a model for making new semi-synthetic and synthetic compounds with improved biological activity [2]. The search for new drugs has led to the testing of naturally occurring compounds from marine environment [3]. Marine macroalgae produce a number of structurally different compounds that exhibit various pharmacological properties [4,5,6], including antiviral, antibacterial, antifungal, cytotoxic [7], insecticidal, antihelmitic, antifeedant, antioxidant, anti-inflammatory [5,7], and antitumor properties [8]. The algae are also source of nutrients [9], containing carbohydrates, amino acids, fatty acids, fibers, vitamins (A, C, B1, B2, B6, and niacin), and minerals (iodine, potassium, magnesium, and calcium). In addition to primary metabolites, algae also produce a large variety of natural organic compounds, which do not play a prominent role in primary metabolism [10]. Such substances are called secondary (specialized) metabolites and are produced in specialized cells. Terpenes (monoterpenes, sesquiterpenes, and diterpenes) are algal and plants specialized metabolites [10,11]. They are a large and structurally diverse group of compounds (isoprenoids) of the general formula (C5H8)n containing isoprene unit (2-methylbuta-1,3-diene) that are found in the volatile oils from land plants and seaweeds [11]. Marine monoterpenes remained undiscovered until 1955 when seven monoterpenes of green alga Ulva pertusa Kjellman were reported [12]. The first unusual marine monoterpenes were not identified until 1973 when the isolation of polyhalogenated compounds from Aplysia californica J.G. Cooper was done [13,14]. During the last decades, following these initial discoveries, new marine monoterpenes have been reported including degraded monoterpenes and monoterpenes of mixed biogenesis [15,16,17,18].
This review highlights the occurrence of monoterpenes in macroalgae with emphasis on the cyclic and halogenated monoterpenes since they were the most active. Macroalgal monoterpenes extraction techniques, methods for the analysis, and structure elucidation are presented, as well as their bioactivity. Available literature, including reviews on biochemistry, biosynthesis, and bioactivity have been focused mainly on monoterpenoids from terrestrial plants [19,20,21,22,23,24,25,26]. Several reviews on marine volatile halogenated metabolites (including monoterpenes) exist [7,27,28,29,30,31]. Neither of these reviews represented comprehensively all domains which are presented in this paper. Kladi et al. [27] not only put an emphasis on monoterpenes, but also on other volatile metabolites present in red algae with short description of their bioactivities. Cabrita et al. [28] reported only few halogenated monoterpenes with antiplasmodial activity. Ibrahim et al. [30] in the review mentioned only the insecticidal activity of few monoterpenes. El Gamal [7] covered all bioactive compounds present in the algae and, among them, emphasized monoterpenes as anticancer agents. Monoterpenes were also reviewed with other nutrients and secondary metabolites of the macroalgae [29]. Zatelli et al. [31] represented that brown algae of the genus Dictyopteris also contained some monoterpenes but in much lower concentration when compared to red algae. In distinction to the published reviews, the present review presents several novelties: (a) exclusively monoterpenes (acyclic, monocyclic, and bicyclic) from red macroalgae, as the main source of monoterpenes, were targeted; (b) the methods of their isolation, analysis, and structure elucidation were systematically summarized in the tables; (c) the bioactivity (anticancer, antiplasmodial, and insecticidal) of macroalgal monoterpenes was systematically presented; (d) the literature references were updated.

2. Biosynthesis of Monoterpenes in Macroalgae

Available literature for the biosynthesis of monoterpenes focus mostly on the algae belonging to the class Rhodophyta (red algae). The halogenated monoterpenes were found in the marine algae and they were synthesized mostly for chemical defense from herbivores [32]. Bromine and chlorine ions are abundant in seawater and involved in the formation of halogenated monoterpenes promoted by bromoperoxidase which is present in many red algae species [33]. A wide variety of these compounds was found in three genera of red algae including Ochtodes, Plocamium, and Portieria [34,35].

2.1. Mevalonate (MVA) Pathway and Methylerithritol Phosphate (MEP) Pathway

Two pathways are known for the biosynthesis of monoterpenes, and the first step includes the formation of the central building blocks of all isoprenoids (known as active isoprenes) isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). They can be formed by mevalonate (MVA) pathway and methylerythritol phosphate (MEP) pathway which is also known as deoxyxylulose-5-phosphate (DXP) pathway (Figure 1). Each of these pathways can occur in the algae cells. For instance, green algae possess only MEP pathway, while several red algae contain both or only one of the mentioned pathways. Lohr et al. [36] also suggested that further genomic sequencing of species is expected to provide more evidence for distribution of these two pathways. The MVA pathway occurred in the cytosol, while the MEP pathway is localized in the plastids, but both have the same task-to form IPP and DMAPP for the synthesis of the key intermediate geranyl pyrophosphate (GPP) [37].
Even though the MVA pathway was discovered in 1950s in yeasts and animals, it is still considered to be the main route of IPP and DMAPP synthesis. It begins with condensation of three molecules of acetyl-CoA followed by the enzymatically assisted conversions for the formation of IPP, all occurring in the cytosol. Six different enzymes are involved in the formation of IPP with the phosphorylation of mevalonate by mevalonate kinase as the main reaction, while the seventh enzyme is responsible for the generation of DMAPP from IPP [36,38].
In contrast to the MVA pathway, the MEP pathway was discovered in 1990s in bacteria and plants. It begins with the reactions between glyceraldehyde-3-phosphate (G3P) and pyruvate and it is capable of producing both IPP and DMAPP as final products due to the presence of the enzyme 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (HDR) [36,39]. IPP is isomerized to DMAPP, which than reacts with IPP within the precursor pool and forms geranyl pyrophosphate (GPP), known as the common precursor for all monoterpenes [40].

2.2. Biosynthesis of Cyclic Monoterpenes in Macroalgae

Although GPP is considered as the universal precursor for monoterpene biosynthesis, it has limited flexibility for the formation of mono- and bicyclic carbon skeletons. Namely, GPP trans-2,3-double bond prevents direct cyclization. Consequently, the enzyme-catalyzed cyclization of GPP and its conversion into tertiary allylic isomer, linalyl pyrophosphate (LPP), occurs in formation of cyclic monoterpenes. The most important step of this mechanism in the algae is the initiation of divalent cation-assisted ionization of the pyrophosphate group which will allow rotation around new single bond and new highly reactive carbocation intermediate is formed, cyclic α-terpinyl cation (Figure 2). α-Terpinyl cation intermediate will undergo several mechanisms such as oxidation, reduction, isomerization, or conjugation, and it will generate a variety of monoterpene cyclic and bicyclic carbon skeletons [41,42]. Figure 2 shows the mechanism of formation of various monoterpene structures from left-handed helical conformer of GPP, but a similar pathway would occur from GPP right-handed helix which would result in the stereochemical antipodes of formed structures.
Wise et al. [41] tested neryl pyrophosphate (NPP), cis-isomer of GPP, and LPP as alternate substrates for monoterpene synthesis. The results showed that myrcene synthase exhibited the ability to form cyclic structures from NPP and LPP resulting in different product profiles. Limonene was produced from NPP, while the mix of products was utilized from LPP, such as myrcene, cis-ocimene, terpinene, and limonene. Although the enzyme is capable for cyclization of NPP and LPP, it does not catalyze the isomerization of GPP to an intermediate that is able to cyclize. Moreover, they demonstrated for the first time in vitro activity of monoterpene synthase from marine source, which provided the basis for understanding and further exploration of biosynthesis of halogenated monoterpenes.

2.3. Biosynthesis of Halogenated Monoterpenes in Macroalgae

Acyclic monoterpenes from macroalgae with bromine or chlorine atoms or both are likely the result of haloperoxidase action on either myrcene or ocimene [33,43]. Bromonium ion-initiated cyclization was proposed to explain the formation of ochtodane ring (l-ethylidene-3,3-dimethylcyclohexane) found in marine monoterpenes [44] from myrcene. Thus, the ring closure is initiated by bromonium attack on C6–C7 olefin followed by internal addition to the resulting cationic center (Figure 3). Similar reasoning invokes ocimene as the immediate precursor of 1,3-dimethyl-l-vinylcyclohexane ring and 2,4-dimethyl-1-vinylcyclohexane ring [35]. The biogenetic schemes presented in Figure 3 are based on relevant chemical models [45,46,47] and successfully predict halogenation patterns and ring structures observed in the algae.
As mentioned previously, red algae are known for their content of halogenated monoterpenes which are characterized by multiple halogen substitutions [35]. They can be produced as the consequence of conversion of GPP to myrcene with myrcene synthase followed by myrcene halogenation, with the help of haloperoxidases, to mono- or dihalogenated myrcene derivatives [48]. Myrcene and ocimene are immediate precursors for the formation of halogenated cyclic compounds. According to Naylor et al. [35], macroalgae belonging to the genus Plocamium, contain ocimene as the common precursor of halogenated monoterpenes, while species from Portieria and Ochtodes contain myrcene as the precursor of halogenated monoterpenes. However, myrcene is not the only one responsible for the biosynthesis of halogenated monoterpenes since the enzyme co-factors exhibit the key role in their synthesis. Without certain enzyme co-factors, halogenated monoterpenes could not be synthesized. Polzin et al. [49] demonstrated that Ochtodes secundiramea (Montagne) M. Howe was not able to synthesize halogenated monoterpenes without the presence of bromide and vanadate which are bromoperoxidase co-factors. This was also confirmed by Polzin and Rorrer [40] when they removed bromide and vanadate from the medium of O. secundiramea and consequently bromoperoxidase-catalyzed halogenation did not occur which indicated that bromide and vanadate are required for the biosynthesis of brominated and bromochlorinated monoterpenes in O. secundiramea. Furthermore, it was found that Portieria hornemannii (Lyngbye) P.C. Silva contains only chlorinated monoterpenes, while Ochtodes secundiramea does not, which indicates the variations in halogenation enzyme activity [34]. Moreover, it could not be said for certain that the cyclization of myrcene to ochtodane and other related structures is catalyzed by the enzymes. Fenical [50] showed that the cyclization can occur without the enzyme catalysis in the presence of bromonium ion, while Barahona and Rorrer [34] showed that P. hornemannii possess chlorination enzyme which does not require bromonium ion intermediate. Barahona and Rorrer [34] proposed that halogenation of monoterpenes is the consequence of Markovnikov addition of the halogen to the olefinic bond of myrcene which is attacked by the halonium ions.

3. Isolation and Biodiversity of Monoterpenes from Macroalgae

Isolation of monoterpenes from macroalgae belonging to the genus Plocamium has been of most interest to various researchers due to the presence of halogenated monoterpenes. The most monoterpenes were isolated from Plocamium cartilagineum (Linnaeus) P.S. Dixon collected from different parts of the world (Table 1).

3.1. Comparison of Different Extraction Methods for the Isolation of Monoterpenes

Monoterpenes have been mostly extracted with different solvents, which are presented in Table 1. These methods belong to the group of conventional extraction methods, but Gao and Okuda [51] used supercritical fluid extraction with CO2 (SC-CO2) for the extraction of monoterpenes (1–8, Figure 4) from P. cartilagineum collected from two different locations, Santa Cruz and San Diego. They used two reference compounds, (6) and (7), for determination of the extraction efficiency of SC-CO2. SC-CO2 with pure CO2 and with the addition of co-solvent methanol was investigated as well as the influence of time and pressure on the extraction yield of monoterpenes. The extraction with pure CO2 gave lower yields, as well as the incomplete profile of monoterpenes when compared with the extraction with methanol as co-solvent. For obtaining the main monoterpenes from P. cartilagineum, additional methanol extraction with a reused algae sample was applied and several monoterpenes were detected in the residual material which remained after SC-CO2 with methanol as co-solvent. The yield of the compounds (6) and (7) was much lower compared to the conventional extraction which can be the consequence of applied process conditions when many unwanted compounds were extracted and interfered with monoterpenes during gas chromatography and mass spectrometry (GC-MS) analysis. Another observation was that the compound (6) was unstable and it decomposed during the conventional extraction from P. cartilagineum probably due to the presence of an aldehyde group which is sensitive to air oxidation. When comparing conventional and supercritical extraction of monoterpenes, it can be concluded that with supercritical extraction monoterpenes could not be oxidized (their original structure is maintained), while during the conventional extraction these compounds can be oxidized. Namely, the conditions during supercritical extraction are almost oxygen free so the potential of oxidation of the compound (6) was reduced. However, the oxidation can also occur during the analysis such as GC [52]. To determine the losses and degradation of certain compounds, external standards with similar or the same chemical structures as the target compound could be used [51,52]. In addition, Gao and Okuda [51] observed that the collection location of the algae showed significant influence on monoterpene profile. The supercritical extraction could selectively extract halogenated monoterpenes from Santa Cruz P. cartilagineum when the pressure and time of the extraction were combined. On the other hand, when San Diego P. cartilagineum was extracted with supercritical fluid extraction, the selectivity of halogenated monoterpenes was not found.

3.2. Monoterpenes Isolated from Different Macroalgae Species

Monoterpenes are divided into cyclic and acyclic groups, with cyclic monoterpenes being mono- or bicyclic. Regular acyclic monoterpenes are head-tail linked (the branched end of one isoprene unit binds to the unbranched end of another isoprene unit).
Figure 5 shows the most significant representatives of acyclic monoterpenes found in the algae: Myrcene (9), ocimene (10), geranial (11), neral (12), citronellol (13), and geraniol (14). The most pleasant odorous compounds found in the algae [53] are included in acyclic group of monoterpenes.
Monocyclic monoterpenes are usually derived from methyl-isopropyl cyclohexane by its dehydrogenation [54]. 1,8-Cineole (15) is the most common monocyclic monoterpene found in the algae [53,55], while α-pinene (16) and β-pinene (17) are the most common representatives of the bicyclic monoterpenes (Figure 6) [53,56].
Even though monoterpenes isolated from macroalgae have been known for centuries, new emerging methods of their isolation and analysis allowed further research of these compounds with the discovery of many new monoterpenes produced by macroalgae (Figure 7, Table 1). Four new monoterpenes based on 1-(2-chlorovinyl)-2,4,5-trichloro-1,5-dimethylcyclohexane skeleton, (18–21), and four known cyclic monoterpenes, (22–25), were isolated and characterized from P. cartilagineum collected along the central coast of Chile [57]. Darias et al. [58] collected this alga also from Chilean coast and found that isolated tetrahydrofuran monoterpenes, furoplocamioids A–C (26–31), contained a chlorobromo vinyl functional group which is unusual among the macroalgae monoterpenes. It is known that monoterpenes isolated from the algae of Plocamium genus possess terminal bromovinylic or chlorovinylic system, but the findings of dihalovinyl system enabled the discovery of regiochemistry of new polyhalogenated monoterpenes. Hence, P. cartilagineum collected at the same location was investigated for its minor constituents to better understand the formation of oxane ring-containing monoterpenes. Diaz-Marrero et al. [59] described two new tetrahydrofuran halogenated monoterpenes (32, 33), as well as new acyclic polyhalogenated monoterpene (34). P. cartilagineum collected from the Spanish coast contained two new polyhalogenated acyclic monoterpenes, (35) and (36) [60]. König, Wright, and Sticher [61] confirmed that the location influenced the secondary metabolites of P. cartilagineum, while in 1999, König, Wright, and Linden [16] observed this pattern in Plocamium hamatum J. Agardh collected from different regions in Australia and reported the compounds (37–47).
In 1979, Stierle and Sims [62] studied P. cartilagineum collected in Antarctica and found several monoterpenes as minor constituents, while Shilling et al. [63] found that these monoterpenes were present at higher concentrations in the same alga species collected also in Antarctica, but during different seasons. The compounds (48–51) were discovered as new, undescribed halogenated monoterpenes from P. cartilagineum, named anverenes B–E.
A recent study by Knott et al. [64] stated that red algae of the families Plocamiaceae and Rhizophyllidaceae developed pathways to oxidize chloride and bromide ions from seawater and incorporate them into monoterpene structures. This resulted in a wide variety of different cyclic and acyclic monoterpenes with multiple halogen atoms, mostly chloride and bromine [27]. Although P. cartilagineum was the most studied algae of the genus Plocamium, the authors observed that other algae from the same genus also produce halogenated monoterpenes. Knott et al. [17] first reported -CHCl2 moiety at C-1 position of three new ocimene-type polyhalogented monoterpenes, plocoralides A–C (52–54), as well as three known compounds (55–57) from Plocamium corallorhiza (Turner) J.D. Hooker and Harvey collected from the coast of South Africa. Mann et al. [18] observed that P. corallorhiza contained unusual moieties attached to monoterpene skeleton. They isolated four new unstable halogenated monoterpene aldehydes (58–61) which were not detected in the algae collected from the west coast of South Africa, but they were present in the macroalgae from the southeastern coast. According to the similar structure to known compounds, such as plocoralide B, they suggested that the compounds (58–61) were degradation products formed during the isolation. The aldehyde group at C-1 is usually characteristic to terrestrial monoterpenes but they were first to report this functional group in marine halogenated monoterpenes. Knott et al. [64] described the isolation and characterization of two novel monoterpenes, halogenated cyclohexanone derivatives, plaxenone A and plaxenone B (62, 63) from Plocamium maxillosum (Poiret) J.V. Lamouroux. A recent study on Plocamium angustum (J. Agardh) J.D. Hooker and Harvey from New Zealand revealed the presence of new polyhalogenated monoterpene with tetrahydropyran ring, costatone C (64), isolated from this species for the first time [65], while costatone A (65) [66] and costatone B (66) [67] were isolated earlier from different Plocamium costatum (C. Agardh) J.D. Hooker and Harvey samples collected in South Australia.
Several monoterpenes are very unstable and during their isolation degradation can occur. During the last few years, a new hyphenated technique, high-performance liquid chromatography–nuclear magnetic resonance (HPLC-NMR), has been employed for obtaining the chemical profile of the genus Plocamium. This technique is non-destructive and all of the isolated compounds are fully recovered. Dias and Urban [68] successfully used this technique to obtain phytochemical profile of Plocamium mertensii (Greville) Harvey which represents the first application of this technique on marine algae. While they obtained the mixture of compounds and isolated other compounds besides monoterpenes, Timmers et al. [69] used this technique to obtain and identify two pure monoterpene compounds. First, they obtained an already known compound, plocamenone (67), from Plocamium angustum and then they identified its unstable double bond isomer isoplocamenone (68) and concluded that this is a very valuable method for the analysis of unstable compounds. On the other hand, Motti et al. [67] used the HPLC-UV-MS-SPE-NMR technique for determination of halogenated monoterpenes from P. costatum and P. hamatum. This technique is relatively new and it combines traditional and hyphenated chromatographic techniques which employs solid-phase extraction (SPE) as an interface between traditional chromatography, ultraviolet spectroscopy (UV), liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR). It has the advantage over HPLC-NMR technique because the analytes trapped on SPE cartridge are eluted with minimal volumes of solvent directly into NMR flow-probe. The results indicated new halogenated monoterpenes including the compounds (66, 69–75), and two known halogenated monoterpenes (76) and (77). The compound (70) was isolated as the mixture with compound (71) at the ratio of 2:1. These two compounds showed similar 1H NMR spectrum with only very slight differences in their chemical shifts (ΔδH 0.1), indicating that these two compounds are stereoisomers. However, their absolute configuration was unassigned.
Similar as genus Plocamium, genus Portieria showed differentiation of monoterpene content depending on the collection location, as was shown by Wright et al. [70] during the isolation of compounds (78–82) from Portieria hornemannii collected in Australia. Gunatilaka et al. [71] isolated two new regioisomeric tetrahalogenated mnonoterpenes, named apakaochtodene A (83) and apakaochtodene B (84), from P. hornemannii collected from different reef sites on Guam with different ratios.
Even though most of the studies are reported on Plocamium and Portieria genera (as the most promising producers of both cyclic and acyclic halogenated monoterpenes), genus Ochtodes also contained halogenated monoterpenes [40,48]. Paul et al. [32] isolated 13 new cyclic monoterpenes (85–97) from red alga Ochtodes crockeri Setchell and N.L. Gardner from the Galapagos Islands. In 1976, Crews et al. [72] observed that halogenated monoterpenes found in Microcladia differ in the composition between different collection locations. They compared Microcladia with Plocamium species [73] with respect to the similarity of monoterpenes profile. Based on the results they concluded that the unique pattern of monoterpene structures for differentiation of algae species cannot be applied because the species belonging to Microcladia and Plocamium can produce similar or the same monoterpenes. Even though they were collected from different locations, plocamene-B (98), plocamene-C (99), violacene (100), and plocamene-D (101) were found in all species of the both genera Microcladia and Plocamium. The compounds present in both genera were related to dechlorobromination and dehydrobromination, while bromine appeared to be the most often incorporated into monoterpenes.

4. Bioactivity of Monoterpenes in Macroalgae

Scientists have shown interest for the bioactivity of monoterpenes isolated exclusively from red algae, with genus Plocamium and Portieria as dominating. El Gamal [7] represented red algae as the main source of monoterpenes with cytotoxic activity. As demonstrated in Table 2, anticancer activity of monoterpenes against different tumor cell lines, including esophageal [74], brain, renal, colon [75], and cervical cancer [76], was the main bioactivity of novel monoterpenes as well as those that were known before.
Among all of isolated monoterpenes, halomon is the best-studied halogenated monoterpene isolated from Portieria hornemannii whose structure is presented in Figure 8. It was firstly isolated and elucidated by Fuller et al. [75]. Halomon (102) was tested for cytotoxicity against human brain, colon, and renal tumor cell lines and the results indicated high cytoxicity against mentioned cell lines, while lower activity was observed against leukemia and melanoma cell lines. Interestingly, P. hornemannii collected from different locations showed the absence of halomon, but new monocyclic monoterpene (103) with lower cytotoxic activity was observed. Plocamium hamatum collected from six different locations showed significant difference within the content of secondary metabolites which led to different cytotoxic results [16].
The structural diversity among halogenated monoterpenes (Figure 9) has been shown as the important factor for bioactivity intensity. De la Mare et al. [77] isolated monoterpene compounds (54, 55, 58, 60, 104–109) and observed that all of them contained from two to five halogen moieties, specifically Cl and/or Br. They selected the molecules whose terpene backbone was identical, but the halogen substitution varied between the compounds. The results indicated that a higher number of halogen atoms resulted in higher anticancer activity against breast cancer cells. Five halogen atoms were found among the most toxic compounds, while non-toxic compounds contained three and four halogens. Hence, the most active against breast cancer cells was the compound which contained only Cl atoms, without Br. When halomon-related halogenated monoterpenes (110–112) were isolated and tested for cytotoxicity, the results showed that the halogen at position C-6 was essential for the certain activity [78].
Due to relatively simple structures of the algal compounds, they can be used for novel chemotherapeutics. Even though their activity is lower than commercially used chemotherapeutics, their structures, along with their differential toxicity, promise novel mechanisms of action against cancer cell lines. Further studies should be performed to develop further modifications for the enhancement of their activity. However, Antunes et al. [74] observed that the cytotoxic activity of halogenated monoterpenes (5, 113–118) from Plocamium suhrii Kützing and Plocamium cornutum (Turner) Harvey was higher when compared to the known anticancer drug cis-platin. Knott et al. [17] showed that plocoralides A–C (52–57), polyhalogenated monoterpenes from Plocamium corallorhiza, exhibited good activity against human esophageal cancer cell lines when compared to the commonly used cis-platin. It can be observed that the genus Plocamium produces a great variety of polyhalogenated monoterpenes with various anticancer activities (Table 2). Sabry et al. [79] isolated one new halogenated monoterpene (119) from P. cartilagineum collected from South Africa. It showed good cytotoxic activity against the cells of human lung cancer and mouse neuro-2a cell lines. Halomon 102 along with the compounds 120–124 isolated from Portieria hornemannii were good inhibitors against DNA methytransferase-1 isoform, which represents the enzyme responsible for tumor growth [80]. De Ines et al. [76] showed that halogenated monoterpenes could have selective activity against certain cancer cell lines. Among isolated compounds (30, 125, 126, 127–132) from P. cartilagineum, the most potent activity exhibited the compounds 30, 125, 126, and 128 with notably selective cytotoxicity against colon and cervical adenocarcinoma cells. Halogenated monoterpenes 62 and 63 isolated from Plocamium maxillosum were tested against MDA-MB-231 metastatic breast carcinoma cell line and showed moderate antiproliferative activity [64]. This level of activity of both of the compounds 62 and 63 is comparable with the previously reported activities of halogenated monoterpenes (54, 55, 58, 60, 104–109) against the same cancer cell lines [77].
Geographical variation, except on anticancer activity, showed also an influence on antiplasmodial activity of halogenated monoterpenes isolated from Plocamium cornutum [81]. Afolayan et al. [81] also emphasized the importance of dichloromethyl moiety at position 7 when considering the higher antiplasmodial activity of halogenated monoterpenes. They observed that two novel compounds 134 and 135 containing 7-dichloromethyl moiety showed significantly higher activity toward strains of Plasmodium falciparum compared with already known compounds 53, 58, 133–135, 138, and 139. Furthermore, two novel cyclohexane polyhalogenated monoterpenes 140 and 141 and furoplocamioid C (30) reported earlier [58] were very efficient repellents and antifeedants, as well as selective insect cell toxicants depending on the number of halogenated substituents, as well as halogen type. Strong antifeedant activity was observed when five halogen substituents were present in monoterpene skeleton, but when compared to six halogen substituents the activity was significantly decreased. The substitution of Br atom showed higher activity of the molecule when compared with C-l atom [82].
According to Watanabe et al. [83], red algae belonging to the genus Plocamium exhibit strong insecticidal activities (Table 2). They studied two polyhalogented monoterpenes, aplysiaterpenoid A (142) and telfairine (143), isolated from Plocamium telfairiae (W.J. Hooker and Harvey) Harvey ex Kützing and tested their insecticidal activities against Blatella germanica and Anopheles gambiae. Aplysiaterpenoid A (142) and telfairine (143) possess cyclodiene-type insecticidal mode of action due to the orientations of the sterically bulky regions and electronegative centers in monoterpenes. In that way, the geometrical requirement for the interaction of monoterpenes with picrotoxinin receptor in tested insects was satisfied, while large volumes of both monoterpenes led to the loose fitting into the receptor. Monoterpenes isolated from Plocamium cartilagineum also showed insecticidal activities. Specifically, the compounds 18–25 were tested against several species of insects among which violacene (19) showed the highest activity against Macrosteles facifrons [57]. Rovirosa et al. [84] also isolated monoterpenes from Plocamium cartilagineum collected from Antarctica. The compound 144 showed the most potent activity against Heliothis virescens, while the compound 145 showed a mild activity against Diabrotica undecimpunctata.
On the other hand, some authors tested the extracts obtained with different methods from various macroalgae species. Machado et al. [85] showed that the obtained extracts with the highest concentration of monoterpenes exhibited acetylcholinesterase inhibition (AChEI). According to the presence of halogenated monoterpenes, Ochtodes secundiramea showed the most potential for AChEI activity. Further studies are necessary for understanding the activity mechanism.

5. Conclusions

The structural diversity of macroalgal monoterpenes is influenced by the habitat of macroalgae (different light exposure and water temperature), as well as the season of their collection. Among the macroalgae belonging to the same genus, there are variations in terms of monoterpene profile and in the ratios of present monoterpenes, while some of monoterpenes are even absent. Even though some species (as those belonging to the genus Plocamium) were very well investigated in the past, the diversity of monoterpenes and the application of new hyphenated techniques lead to the discovery of new and yet unknown monoterpenes in the last few years. In this paper, the total of 136 different structures of monoterpenes isolated from the genera Plocamium, Protieria, Ochtodes, and Microcladia were shown along with nine structures of commercially known monoterpens which can be found in other plants, as well as in the algae. According to the literature presented, red algae from the genus Plocamium are the largest source of acyclic and cyclic monoterpenes. Moreover, with more than 100 isolated monoterpenes, Plocamium species are one of the most important macroalgal sources of these compounds. Halogenation is characteristic for macroalgal monoterpenes due to the capability of algae to synthesize diverse halogenated monoterpenes with the help of haloperoxidases present in their cells and/or Markovnikov addition of the halogen on the precursor which is attacked by the halonium ions. Macroalgal monoterpenes are mostly halogenated with one or more chlorine and/or bromine atoms in their structure.
Numerous studies have shown that monoterpenes isolated from macroalgae exhibit anticancer, insecticidal and antiplasmodial activity, while the extracts rich in monoterpenes exhibited acetylcholinesterase inhibition, but further elucidation about the activity mechanisms should be performed. It was shown that the structure of monoterpenes affects the bioactivity intensity. Higher halogen substitution leads to the better cytotoxicity and five halogen atoms were found as optimal. Hence, halogenated monoterpenes with only C-l atoms showed higher activity.
Due to the fact that the marine biodiversity is greater than terrestrial, the discovery of new monoterpenes is expected to increase.

Author Contributions

All authors discussed and planned the paper; A.-M.C., M.J., and I.J. drafted the manuscript; S.J. and R.Č.-R. reviewed and edited the manuscript; funding acquisition: I.J., S.J., and R.Č.-R.

Funding

This research was funded by the Croatian Government and the European Union through the European Regional Development Fund-the Competitiveness and Cohesion Operational Programme (KK.01.1.1.01) The Scientific Centre of Excellence for Marine Bioprospecting-BioProCro.

Acknowledgments

This research was supported by the Croatian Government and the European Union through the European Regional Development Fund-the Competitiveness and Cohesion Operational Programme (KK.01.1.1.01) The Scientific Centre of Excellence for Marine Bioprospecting-BioProCro.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mann, J. Natural products in cancer chemotherapy: Past, present and future. Nat. Rev. Cancer 2002, 2, 143–148. [Google Scholar] [CrossRef] [PubMed]
  2. Simmons, T.L.; Andrianasolo, E.; McPhail, K.; Flatt, P.; Gerwick, W.H. Marine natural products as anticancer drugs. Mol. Cancer Ther. 2005, 4, 333–342. [Google Scholar] [PubMed]
  3. Ramawat, K.G.; Goyal, S. Chapter 10—Natural Products in Cancer Chemoprevention and Chemotherapy. In Herbal Drugs: Ethnomedicine to Modern Medicine; Ramawat, K.G., Ed.; Springer: Berlin, Germany, 2009; pp. 153–171. ISBN 978-3-540-79116-4. [Google Scholar]
  4. Perez, M.J.; Falque, E.; Dominguez, H. Antimicrobial Action of Compounds from Marine Seaweed. Mar. Drugs 2016, 14, 52. [Google Scholar] [CrossRef] [PubMed]
  5. Shukla, S. Secondary metabolites from marine microorganisms and therapeutic efficacy: A mini review. Indian J. Geo Mar. Sci. 2016, 45, 1245–1254. [Google Scholar]
  6. Bajpai, V.K. Antimicrobial bioactive compounds from marine algae: A mini review. Indian J. Geo Mar. Sci. 2016, 45, 1076–1085. [Google Scholar]
  7. El Gamal, A.A. Biological importance of marine algae. Saudi Pharm. J. 2010, 18, 1–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Kong, C.S.; Kim, J.A.; Yoon, N.Y.; Kim, S.K. Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food Chem. Toxicol. 2009, 47, 1653–1658. [Google Scholar] [CrossRef]
  9. Torres, F.A.E.; Passalacqua, T.G.; Velásquez, A.M.A.; De Souza, R.A.; Colepicolo, P.; Graminha, M.A.S. New drugs with antiprotozoal activity from marine algae: A review. Rev. Bras. Farmacogn. 2014, 24, 265–276. [Google Scholar] [CrossRef]
  10. Agostini-Costa, T.S.; Vieira, R.F.; Bizzo, H.R.; Silveira, D.; Gimenes, M.A. Chapter 8—Secondary metabolites. In Chromatography and Its Applications; Dhanarasu, S., Ed.; InTech: London, UK, 2012; pp. 131–164. ISBN 978-953-51-0357-8. [Google Scholar]
  11. El Shoubaky, G.A.; Salem, E.S. Terpenes and Sterols Composition of Marine Brown Algae Padina pavonica (Dictyotales) and Hormophysa triquetra (Fucales). Int. J. Pharmacogn. Phytochem. Res. 2014, 6, 894–900. [Google Scholar]
  12. Katayama, T. The Volatile Constituents of Seaweed. III. The Terpenes of Volatile Constituents of Ulva pertusa. Bull. Jpn. Soc. Sci. Fisheries 1955, 21, 412–415. [Google Scholar] [CrossRef]
  13. Faulkner, D.J.; Stallard, M.O. 7-Chloro-3,7-dimethyl-1,4,6-tri-bromo-1-octen-3-ol, A Novel Monoterpene Alcohol from Aplysia californica. Tetrahedron Lett. 1973, 14, 1171–1174. [Google Scholar] [CrossRef]
  14. Faulkner, D.J.; Stallard, M.O.; Fayos, J.; Clardy, J. (3R, 4S, 7S)-trans,trans-3,7-dimethyl-1,8,8-tribromo-3,4,7-trichloro-1,5-octadiene, a Novel Monoterpene from the Sea Hare, Aplysia californica. J. Am. Chem. Soc. 1973, 95, 3413–3414. [Google Scholar] [CrossRef]
  15. Paul, V.J.; Hay, M.E.; Duffy, E.; Fenical, W.; Gustafson, K. Chemical defense in the seaweed Ochtodes secundiramea (Montagne) Howe (Rhodophyta): Effects of its monoterpenoid components upon diverse coral-reef herbivores. J. Exp. Mar. Biol. Ecol. 1987, 114, 249–260. [Google Scholar] [CrossRef]
  16. König, G.M.; Wright, A.D.; Linden, A. Plocamium hamatum and its monoterpenes: Chemical and biological investigations of the tropical marine red alga. Phytochemistry 1999, 52, 1047–1053. [Google Scholar] [CrossRef]
  17. Knott, M.G.; Mkwananzi, H.; Arendse, C.E.; Hendricks, D.T.; Bolton, J.J.; Beukes, D.R. Plocoralides A–C, polyhalogenated monoterpenes from the marine alga Plocamium corallorhiza. Phytochemistry 2005, 66, 1108–1112. [Google Scholar] [CrossRef] [PubMed]
  18. Mann, M.G.A.; Mkwananzi, H.B.; Antunes, E.M.; Whibley, C.E.; Hendricks, D.T.; Bolton, J.J.; Beukes, D.R. Halogenated Monoterpene Aldehydes from the South African Marine Alga Plocamium corallorhiza. J. Nat. Prod. 2007, 70, 596–599. [Google Scholar] [CrossRef]
  19. De Mayo, P. Mono- and Sesquiterpenoids. In The Chemistry of Natural Products; Bratley, K.W., Ed.; Interscience: New York, NY, USA, 1959; pp. 1–179. [Google Scholar]
  20. Ružička, L. History of the Isoprene Rule. Proc. Chem. Soc. 1959, 341. [Google Scholar] [CrossRef]
  21. Devon, T.K.; Scott, A.I. Handbook of Naturally Occurring Compounds; Academic Press: New York, NY, USA, 1972; p. 576. [Google Scholar]
  22. Cavill, G.W.K. Insect Terpenoids and Nepetalactone. In Cyclopentanoid Terpene Derivatives; Taylor, W.I., Battersby, A.R., Eds.; Marcel Dekker: New York, NY, USA, 1969; pp. 203–235. [Google Scholar]
  23. Francis, M.J.O. Monoterpene Biosynthesis. In Aspects of Terpenoid Chemistry and Biochemistry; Goodwin, T.W., Ed.; Academic Press: New York, NY, USA, 1971; pp. 29–48. [Google Scholar]
  24. Poulter, C.D.; Rilling, H.C. The Prenyl Transfer Reaction. Enzymatic and Mechanistic Studies of the 1-4 Coupling Reaction in the Terpene Biosynthetic Pathway. Acc. Chem. Res. 1978, 11, 307–313. [Google Scholar] [CrossRef]
  25. Loomis, W.D. Biosynthesis and Metabolism of Monoterpenes. In Terpenoids in Plants; Pridham, J.B., Ed.; Academic Press: New York, NY, USA, 1967; pp. 59–80. [Google Scholar]
  26. Whittaker, D. The Monoterpenes. In Chemistry of Terpenes and Terpenoids; Newman, A.A., Ed.; Academic Press: New York, NY, USA, 1972; pp. 11–82. [Google Scholar]
  27. Kladi, M.; Vagias, C.; Roussis, V. Volatile halogenated metabolites from marine red algae. Phytochem. Rev. 2004, 3, 337–366. [Google Scholar] [CrossRef]
  28. Cabrita, M.T.; Vale, C.; Rauter, A.P. Halogenated compounds from marine algae. Mar. Drugs 2010, 8, 2301–2317. [Google Scholar] [CrossRef]
  29. Peng, Y.; Hu, J.; Yang, B.; Lin, X.P.; Zhou, X.F.; Yang, X.W.; Liu, Y. Chapter 5—Chemical composition of seaweeds. In Seaweed Sustainability. Food and Non-Food Applications; Tiwari, B.K., Troy, D.J., Eds.; Elsevier: Amsterdam, The Netherlands, 2015; pp. 79–113. ISBN 978-0-12-418697-2. [Google Scholar]
  30. Ibrahim, M.; Salman, M.; Kamal, S.; Rehman, S.; Razzaq, A.; Akash, S.H. Chapter 6—Algae- Based Biologically Active Compounds. In Algae Based Polymers, Blends and Composites; Zia, K.M., Zuber, M., Ali, M., Eds.; Elsevier: Amsterdam, The Netherlands, 2017; pp. 155–271. ISBN 978-0-12-812360-7. [Google Scholar]
  31. Zatelli, G.A.; Philippus, A.C.; Falkenberg, M. An overview of odoriferous marine seaweeds of the Dictyopteris genus: Insights into their chemical diversity, biological potential and ecological roles. Rev. Bras. Farmacogn. 2018, 28, 243–260. [Google Scholar] [CrossRef]
  32. Paul, V.J.; McConnell, O.J.; Fenical, W. Cyclic Monoterpenoid Feeding Deterrents from the Red Marine Alga Ochtodes crockeri. J. Org. Chem. 1980, 45, 3401–3407. [Google Scholar] [CrossRef]
  33. Butler, A.; Walker, J.V. Marine Haloperoxidases. Chem. Rev. 1993, 93, 1937–1944. [Google Scholar] [CrossRef]
  34. Barahona, L.F.; Rorrer, G.L. Isolation of Halogenated Monoterpenes from Bioreactor—Cultured Microplantlets of the Macrophytic Red Algae Ochtodes secundiramea and Portieria hornemannii. J. Nat. Prod. 2003, 66, 743–751. [Google Scholar] [CrossRef]
  35. Naylor, S.; Hanke, F.J.; Manes, L.V.; Crews, P. Chemical and Biological Aspects of Marine Monoterpenes. Fortschr. Chem. Org. Naturst. 1983, 44, 189–241. [Google Scholar] [CrossRef]
  36. Lohr, M.; Schwender, J.; Polle, J.E.W. Isoprenoid biosynthesis in eukaryotic phototrophs: A spotlight on algae. Plant. Sci. 2012, 185, 9–22. [Google Scholar] [CrossRef]
  37. Saeidnia, S.; Gohari, A.R. Chapter 6—Trypanocidal Monoterpenes: Lead Compounds to Design Future Trypanocidal Drugs. In Studies in Natural Product Chemistry; Rahman, A.U., Ed.; Elsevier: Amsterdam, The Netherlands, 2012; pp. 173–190. ISBN 978-0-444-59514-0. [Google Scholar]
  38. Miziorko, H.M. Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch. Biochem. Biophys. 2011, 505, 131–143. [Google Scholar] [CrossRef] [Green Version]
  39. Lombard, J.; Moreira, D. Origins and Early Evolution of the Mevalonate Pathway of Isoprenoid Biosynthesis in the Three Domains of Life. Mol. Biol. Evol. 2011, 28, 87–99. [Google Scholar] [CrossRef]
  40. Polzin, J.; Rorrer, G.L. Selective production of the acyclic monoterpene β-myrcene by microplantlet suspension cultures of the macrophytic marine red alga Ochtodes secundiramea under nutrient perfusion cultivation with bromide-free medium. Algal Res. 2018, 36, 159–166. [Google Scholar] [CrossRef]
  41. Wise, M.J.; Rorrer, G.L.; Polzin, J.J.; Croteau, R. Biosynthesis of Marine Natural Products: Isolation and Characterization of a Myrcene Synthase from Cultured Tissues of the Marine Red Alga Ochtodes secundiramea. Arch. Biochem. Biophys. 2002, 400, 125–132. [Google Scholar] [CrossRef]
  42. Wise, M.J. Monoterpene biosynthesis in marine algae. Phycologia 2003, 42, 370–377. [Google Scholar] [CrossRef]
  43. Hewson, W.D.; Hager, L.P. Bromoperoxidases and halogenated lipids in marine algae. J. Phycol. 1980, 16, 340–345. [Google Scholar] [CrossRef]
  44. Fenical, W. Natural products chemistry in the marine environment. Science 1982, 215, 923–928. [Google Scholar] [CrossRef]
  45. Kato, T.; Ichinose, J.; Kamoshida, A.; Kitahara, Y. Cyclization of polyenes. Biogenetic-type synthesis of snyderols. J. Chem. Soc. Chem. Comm. 1976, 13, 518–519. [Google Scholar] [CrossRef]
  46. Yoshihara, K.; Hirose, Y. The derivation of a brominated algal component from myrcene. B. Chem. Soc. Jpn. 1978, 51, 653–654. [Google Scholar] [CrossRef]
  47. Masaki, Y.; Hashimoto, K.; Sakuma, K.; Kaji, K. New ochtodane syntheses from myrcene. Tetrahedron Lett. 1982, 23, 1481–1484. [Google Scholar] [CrossRef]
  48. Maliakal, S.; Cheney, D.P.; Rorrer, G.L. Halogenated monoterpene production in regenerated plantlet cultures of Ochtodes secundiramea (Rhodophyta, Cryptonemiales). J. Phycol. 2001, 37, 1010–1019. [Google Scholar] [CrossRef]
  49. Polzin, J.J.; Rorrer, G.L.; Cheney, D.P. Metabolic flux analysis of halogenated monoterpene biosynthesis in microplantlets of the macrophytic red alga Ochtodes secundiramea. Biomol. Eng. 2003, 20, 205–215. [Google Scholar] [CrossRef]
  50. Fenical, W. Halogenation in the Rhodophyta. A review. J. Phycol. 1975, 11, 245–259. [Google Scholar] [CrossRef]
  51. Gao, D.; Okuda, R. Supercritical Fluid Extraction of Halogenated Monoterpenes from the Red Alga Plocamium cartilagineum. J. AOAC Int. 2001, 84, 1313–1331. [Google Scholar]
  52. Jiang, Z.; Kempinski, C.; Chappell, J. Extraction and analysis of terpenes/terpenoids. Curr. Protoc. Plant. Biol. 2016, 1, 345–358. [Google Scholar] [CrossRef]
  53. Güven, K.C.; Sezik, E.; Kaleagasiougl, F.; Erdugan, H.; Coban, B.; Karakas, E. Vlatile Oils from Marine Macroalgae. In Natural Products; Ramawat, K.G., Merillom, J.M., Eds.; Springer: Berlin, Germany, 2013; pp. 2883–2912. [Google Scholar]
  54. Koziol, A.; Stryjewska, A.; Librowski, T.; Salat, K.; Gawel, M.; Moniczewski, A.; Lochynski, S. An Overview of the Pharmacological Properties and Potential Applications of Natural Monoterpenes. Mini Rev. Med. Chem. 2014, 14, 1156–1168. [Google Scholar] [CrossRef]
  55. Jerković, I.; Marijanović, Z.; Roje, M.; Kus, P.M.; Jokić, S.; Čož-Rakovac, R. Phytochemical study of the headspace volatile organic compounds of fresh algae and seagrass from the Adriatic Sea (single point collection). PLoS ONE 2018, 13, e0196462. [Google Scholar] [CrossRef]
  56. Marmulla, R.; Harder, J. Microbial monoterpene transformations–A review. Front. Microbiol. 2014, 5, 346. [Google Scholar] [CrossRef]
  57. San-Martin, A.; Negrete, R.; Rovirosa, J. Insecticide and acaricide activities of polyhalogenated monoterpenes from Chilean Plocamium cartilagineum. Phytochemistry 1991, 30, 2165–2169. [Google Scholar] [CrossRef]
  58. Darias, J.; Rovirosa, J.; San Martin, A.; Diaz, A.R.; Dorta, E.; Cueto, M. Furoplocamioids A-C, Novel Polyhalogenated Furanoid Monoterpenes from Plocamium cartilagineum. J. Nat. Prod. 2001, 64, 1383–1387. [Google Scholar] [CrossRef]
  59. Diaz-Marrero, A.R.; Cueto, M.; Dorta, E.; Rovirosa, J.; San-Martin, A.; Darias, J. New halogenated monoterpenes from the red alga Plocamium cartilagineum. Tetrahedron 2002, 58, 8539–8542. [Google Scholar] [CrossRef]
  60. Gonzalez, A.G.; Darias, V.; Estevez, E. Chemotherapeutic Activity of Polhalogenated Terpenes from Spanish Algae. J. Med. Plant. Res. 1982, 44, 44–46. [Google Scholar] [CrossRef]
  61. König, G.M.; Wright, A.D.; Sticher, O. A new polyhalogented monoterpene from the red alga Plocamium cartilagineum. J. Nat. Prod. 1990, 53, 1615–1618. [Google Scholar] [CrossRef]
  62. Stierle, D.B.; Sims, J.J. Polyhalogenated cyclic monoterpenes from the red alga Plocamium cartilagineum of Antartica. Tetrahedron 1979, 35, 1261–1265. [Google Scholar] [CrossRef]
  63. Shilling, A.J.; von Salm, J.L.; Sanchez, A.R.; Kee, Y.; Amsler, C.D.; McClintock, J.B.; Baker, B.J. Anverenes B–E, New Polyhalogenated Monoterpenes from the Antarctic Red Alga Plocamium cartilagineum. Mar. Drugs 2019, 17, 230. [Google Scholar] [CrossRef]
  64. Knott, M.G.; de la Mare, J.A.; Edkins, A.L.; Zhang, A.; Stillman, M.J.; Bolton, J.J.; Antunes, E.M.; Beukes, D.R. Plaxenone A and B: Cytotoxic halogenated monoterpenes from the South African red seaweed Plocamium maxillosum. Phytochem. Lett. 2019, 29, 182–185. [Google Scholar] [CrossRef]
  65. Bracegirdle, J.; Sohail, Z.; Fairhurst, M.J.; Gerth, M.L.; Zuccarello, G.C.; Hasmi, M.A.; Keyzers, R.A. Costatone C – A new halogenated mnonoterpene from the New Zealand red alga Plocamium angustum. Mar. Drugs 2019, 17, 418. [Google Scholar] [CrossRef]
  66. Stierle, D.B.; Wing, R.M.; Sims, J.J. Marine Natural Products XI costatone and costatolide, new halogenated monoterpenes from the red seaweed, Plocamium costatum. Tetrahedron Lett. 1976, 49, 4455–4458. [Google Scholar] [CrossRef]
  67. Motti, C.A.; Thomas-Hall, P.; Hagiwara, K.A.; Simmons, C.J.; Willis, R.; Wright, A.D. Accelerated Identification of Halogenated Monoterpenes from Australian Specimens of the Red Algae Plocamium hamatum and Plocamium costatum. J. Nat. Prod. 2014, 77, 1193–1200. [Google Scholar] [CrossRef]
  68. Dias, D.; Urban, S. Phytochemical Analysis of the Southern Australian Marine Alga, Plocamium mertensii using HPLC-NMR. Phytochem. Anal. 2008, 19, 453–470. [Google Scholar] [CrossRef]
  69. Timmers, M.A.; Dias, D.A.; Urban, S. Application of HPLC-NMR in the Identification of Plocamenone and Isoplocamenone from the Marine Red Alga Plocamium angustum. Mar. Drugs 2012, 10, 2089–2102. [Google Scholar] [CrossRef]
  70. Wright, A.D.; König, G.M.; Sticher, O. Five new monoterpenes from the marine red alga Portieria hornemannii. Tetrahedron 1991, 47, 5717–5724. [Google Scholar] [CrossRef]
  71. Gunatilaka, A.A.L.; Paul, V.J.; Park, P.U.; Puglisi, M.P.; Gitler, A.D.; Eggleston, D.S.; Haltiwanger, R.C.; Kingston, D.G.I. Apakaochtodenes A and B: Two Tetrahalogenated Monoterpenes from the Red Marine Alga Portieria hornemannii. J. Nat. Prod. 1999, 62, 1376–1378. [Google Scholar] [CrossRef]
  72. Crews, P.; Ng, P.; Kho-Wiseman, E.; Pace, C. Halogenated monoterpenes of the red alga Microcladia. Phytochemistry 1976, 15, 1707–1711. [Google Scholar] [CrossRef]
  73. Crews, P.; Kho, E.; Plocamene, B. New cyclic monoterpene skeleton from a red marine alga. J. Org. Chem. 1975, 40, 2568–2570. [Google Scholar] [CrossRef]
  74. Antunes, E.M.; Afolayan, A.F.; Chiwakata, M.T.; Fakee, J.; Knott, M.G.; Whibley, C.E.; Hendricks, D.T.; Bolton, J.J.; Beukes, D.R. Identification and in vitro anti-esophageal cancer activity of a series of halogenated monoterpenes isolated from the South African seaweeds Plocamium suhrii and Plocamium cornutum. Phytochemistry 2011, 72, 769–772. [Google Scholar] [CrossRef]
  75. Fuller, R.W.; Cardellina, J.H.; Kato, Y.; Brinen, L.S.; Clardy, J.; Snader, K.M.; Boyd, M.R. A Pentahalogenated Monoterpene from the Red Alga Portieria hornemannii Produces a Novel Cytotoxicity Profile against a Diverse Panel of Human Tumor Cell Lines. J. Med. Chem. 1992, 35, 3007–3011. [Google Scholar] [CrossRef]
  76. De Ines, C.; Argandona, V.H.; Rovirosa, J.; San-Martin, A.; Diaz-Marrero, A.R.; Cueto, M.; Gonzalez-Coloma, A. Cytotoxic Activity of Halogenated Monoterpenes from Plocamium cartilagineum. Z. Naturforsch. 2004, 59, 339–344. [Google Scholar] [CrossRef]
  77. De la Mare, J.A.; Lawson, J.C.; Chiwakata, M.T.; Beukes, D.R.; Edkins, A.L.; Blatch, G.L. Quinones and halogenated monoterpenes of algal origin show anti-proliferative effects against breast cancer cells in vitro. Invest. New Drugs 2012, 30, 2187–2200. [Google Scholar] [CrossRef]
  78. Fuller, R.W.; Cardellina, J.H.; Jurek, J.; Scheuer, P.J.; Alvarado-Lindner, B.; McGuire, M.; Gray, G.N.; Rios Steiner, J.; Clardy, J.; Menez, E.; et al. Isolation and Structure/Activity Features of Halomon-Related Antitumor Monoterpenes from the Red Alga Portieria hornemannii. J. Med. Chem. 1994, 37, 4407–4411. [Google Scholar] [CrossRef]
  79. Sabry, O.M.M.; Goeger, D.E.; Valeriote, F.A.; Gerwick, W.H. Cytotoxic halogenated monoterpenes from Plocamium cartilagineum. Nat. Prod. Res. 2016, 31, 261–267. [Google Scholar] [CrossRef]
  80. Andrianasolo, E.H.; France, D.; Cornell-Kennon, S.; Gerwick, W.H. DNA Methyl Transferase Inhibiting Halogenated Monoterpenes from the Madagascar Red Marine Alga Portieria hornemannii. J. Nat. Prod. 2006, 69, 576–579. [Google Scholar] [CrossRef]
  81. Afolayan, A.F.; Mann, M.G.A.; Lategan, C.A.; Smith, P.J.; Bolton, J.J.; Beukes, D.R. Antiplasmodial halogenated monoterpenes from the marine red alga Plocamium cornutum. Phytochemistry 2009, 70, 597–600. [Google Scholar] [CrossRef]
  82. Argandona, V.H.; Rovirosa, J.; San-Martin, A.; Riquelme, A.; Diaz-Marrero, A.R.; Cueto, M.; Daria, J.; Santana, O.; Guadano, A.; Gonzalez-Coloma, A. Antifeedant Effects of Marine Halogenated Monoterpenes. J. Agric. Food Chem. 2002, 50, 7029–7033. [Google Scholar] [CrossRef]
  83. Watanabe, K.; Umeda, K.; Kurita, Y.; Takayama, C.; Miyakado, M. Two Insecticidal Monoterpenes, Telfairine and Aplysiaterpenoid A, from the Red Alga Plocamium telfairiae: Structure Elucidation, Biological Activity, and Molecular Topographical Consideration by a Semiempirical Molecular Orbital Study. Pestic. Biochem. Phys. 1990, 37, 275–286. [Google Scholar] [CrossRef]
  84. Rovirosa, J.; Soler, A.; Blanc, V.; Leon, R.; San-Martin, A. Bioactive monoterpenes from Antartic Plocamium cartilagineum. J. Chil. Chem. Soc. 2013, 58, 2025–2026. [Google Scholar] [CrossRef]
  85. Machado, L.P.; Carvalho, L.R.; Young, M.C.M.; Cardoso-Lopes, E.M.; Centeno, D.C.; Zambotti-Villela, L.; Colepicolo, P.; Yokoya, N.S. Evaluation of acetylcholinesterase inhibitory activity of Brazilian red macroalgae organic extracts. Rev. Bras. Farmacogn. 2015, 25, 657–662. [Google Scholar] [CrossRef]
Marinedrugs 17 00537 g001 550
Figure 1. Mevalonate (MVA) and methylerythritol phosphate (MEP) pathway.
Figure 1. Mevalonate (MVA) and methylerythritol phosphate (MEP) pathway.
Marinedrugs 17 00537 g001
Marinedrugs 17 00537 g002 550
Figure 2. The pathway of monoterpene cyclization through divalent cation-assisted ionization of pyrophosphate group and formation of α-terpinyl cation intermediate (I—limonene; II—δ-terpinene; III—γ-terpinene; IV—α-terpinene; V—α-pinene; VI—β-pinene; VII—car-3-ene; VIII—sabinene; IX—borneol; X—camphene; XI—1,8-cineol).
Figure 2. The pathway of monoterpene cyclization through divalent cation-assisted ionization of pyrophosphate group and formation of α-terpinyl cation intermediate (I—limonene; II—δ-terpinene; III—γ-terpinene; IV—α-terpinene; V—α-pinene; VI—β-pinene; VII—car-3-ene; VIII—sabinene; IX—borneol; X—camphene; XI—1,8-cineol).
Marinedrugs 17 00537 g002
Marinedrugs 17 00537 g003 550
Figure 3. The scheme of cyclization of halogenated monoterpene structures.
Figure 3. The scheme of cyclization of halogenated monoterpene structures.
Marinedrugs 17 00537 g003
Marinedrugs 17 00537 g004 550
Figure 4. Monoterpenes isolated with SC-CO2 extraction from Plocamium cartilagineum.
Figure 4. Monoterpenes isolated with SC-CO2 extraction from Plocamium cartilagineum.
Marinedrugs 17 00537 g004
Marinedrugs 17 00537 g005 550
Figure 5. Acyclic monoterpenes.
Figure 5. Acyclic monoterpenes.
Marinedrugs 17 00537 g005
Marinedrugs 17 00537 g006 550
Figure 6. Cyclic monoterpenes.
Figure 6. Cyclic monoterpenes.
Marinedrugs 17 00537 g006
Marinedrugs 17 00537 g007a 550Marinedrugs 17 00537 g007b 550
Figure 7. Isolated halogenated monoterpenes from species of genera Plocamium, Portieira, Ochtodes, and Microcladia.
Figure 7. Isolated halogenated monoterpenes from species of genera Plocamium, Portieira, Ochtodes, and Microcladia.
Marinedrugs 17 00537 g007aMarinedrugs 17 00537 g007b
Marinedrugs 17 00537 g008 550
Figure 8. Chemical structure of halomon.
Figure 8. Chemical structure of halomon.
Marinedrugs 17 00537 g008
Marinedrugs 17 00537 g009 550
Figure 9. Bioactive halogenated monoterpenes isolated from macroalgae.
Figure 9. Bioactive halogenated monoterpenes isolated from macroalgae.
Marinedrugs 17 00537 g009
Table
Table 1. The methods of isolation of halogenated monoterpenes from different macroalgal species.
Table 1. The methods of isolation of halogenated monoterpenes from different macroalgal species.
Macroalgae SpeciesIsolated MonoterpenesExtraction SolventAnalytical MethodReferences
Genus Plocamium
Plocamium cartilagineum1–8Conventional extraction with MeOH and EtOAc; SC–CO2 extraction (pure CO2 and with 10 % MeOH as co-solvent)GC–MS, NMR[51]
Plocamium cartilagineum18–25CHCl3 and EtOHNMR[57]
Plocamium cartilagineum26–31EtOAc–CH2Cl2-hexaneHPLC, NMR[58]
Plocamium cartilagineum32–34hexane/EtOAc/CH2Cl2/MeOHHPLC, NMR[59]
Plocamium cartilagineum35, 36Et2ONMR[60]
Plocamium hamatum37–47CH2Cl2NMR[16]
Plocamium cartilagineum48–51CH2Cl2/H2OGC–MS, HPLC, NMR[63]
Plocamium corallorhiza52–57MeOH and CH2Cl2NMR[17]
Plocamium corallorhiza58–61CH2Cl2–MeOHNMR[18]
Plocamium maxillosum62, 63CH2Cl2–MeOHNMR[64]
Plocamium angustum64MeOHNMR, HPLC[65]
Plocamium costatum65HexaneNMR[66]
Plocamium angustum67, 68CH2Cl2–MeOHHPLC–NMR[69]
Plocamium hamatum, Plocamium costatum66, 69–77CH2Cl2–MeOHHPLC–UV–MS–SPE–NMR[67]
Genus Portieria
Portieria hornemannii78–82MeOH:CH2Cl2NMR[70]
Portieria hornemannii83, 84CH2Cl2/MeOHHPLC, NMR[71]
Genera Ochtodes and Microcladia
Ochtodes crockeri85–97CHCl3:MeOHHPLC[32]
Microcladia coulteri,
M. borealis,
M. californica		98–101CHCI3, CH2Cl2 and EtOH, CHCl3 and EtOHGC–MS, NMR[72]
Table
Table 2. Isolated monoterpenes from different macroalgal species and their bioactivity.
Table 2. Isolated monoterpenes from different macroalgal species and their bioactivity.
Macroalgae SpeciesIsolated MonoterpenesReferences
Anticancer activity
Portieria hornemannii102, 103[75]
Plocamium corallorhiza, Plocamium cornutum54, 55, 58, 60, 104–109[77]
Portieria hornemannii110–112[78]
Polcamium suhrii, Plocamium cornutum5, 113–118[74]
Plocamium corallorhiza52–57[17]
Plocamium cartilagineum119[79]
Portieria hornemannii102, 120–124[80]
Plocamium cartilagineum30, 125, 126, 127–132[76]
Plocamium maxillosum62, 63[64]
Antiplasmodial (antimalarial) activity
Plocamium cornutum53, 58, 133–139[81]
Insecticidal activity
Plocamium cartilagineum, Pantineura plocamioides26, 27, 30, 31, 140, 141[82]
Plocamium telfairiae142, 143[83]
Plocamium cartilagineum18–25[16]
Plocamium cartilagineum144, 145[84]

Share and Cite

MDPI and ACS Style

Cikoš, A.-M.; Jurin, M.; Čož-Rakovac, R.; Jokić, S.; Jerković, I. Update on Monoterpenes from Red Macroalgae: Isolation, Analysis, and Bioactivity. Mar. Drugs 2019, 17, 537. https://doi.org/10.3390/md17090537

AMA Style

Cikoš A-M, Jurin M, Čož-Rakovac R, Jokić S, Jerković I. Update on Monoterpenes from Red Macroalgae: Isolation, Analysis, and Bioactivity. Marine Drugs. 2019; 17(9):537. https://doi.org/10.3390/md17090537

Chicago/Turabian Style

Cikoš, Ana-Marija, Mladenka Jurin, Rozelindra Čož-Rakovac, Stela Jokić, and Igor Jerković. 2019. "Update on Monoterpenes from Red Macroalgae: Isolation, Analysis, and Bioactivity" Marine Drugs 17, no. 9: 537. https://doi.org/10.3390/md17090537

APA Style

Cikoš, A. -M., Jurin, M., Čož-Rakovac, R., Jokić, S., & Jerković, I. (2019). Update on Monoterpenes from Red Macroalgae: Isolation, Analysis, and Bioactivity. Marine Drugs, 17(9), 537. https://doi.org/10.3390/md17090537

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop